BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8290965)

  • 1. Alzheimer's disease and possible gene interaction.
    St George-Hyslop P; McLachlan DC; Tsuda T; Rogaev E; Karlinsky H; Lippa CF; Pollen D
    Science; 1994 Jan; 263(5146):537. PubMed ID: 8290965
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease.
    Selkoe DJ
    Cold Spring Harb Symp Quant Biol; 1996; 61():587-96. PubMed ID: 9246485
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease: phenotypes and genotypes.
    Sorbi S; Forleo P; Nacmias B
    Funct Neurol; 1997; 12(3-4):147-51. PubMed ID: 9218968
    [No Abstract]   [Full Text] [Related]  

  • 4. [Familial Alzheimer's disease by beta-amyloid protein precursor (beta APP) mutations].
    Okochi M; Takeda M
    Nihon Rinsho; 2004 Jan; 62 Suppl():86-9. PubMed ID: 15011326
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in the study of Alzheimer's disease associated genes].
    Tong T; Zhang Z
    Zhonghua Yi Xue Za Zhi; 1999 Feb; 79(2):158-60. PubMed ID: 11601025
    [No Abstract]   [Full Text] [Related]  

  • 6. Apolipoprotein E genotype and Alzheimer's disease. Alzheimer's Disease Collaborative Group.
    Lancet; 1993 Sep; 342(8873):737-8. PubMed ID: 8103833
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease.
    Hsueh W
    Pharmacogenomics J; 2006; 6(4):222-4. PubMed ID: 16865098
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease.
    Egensperger R; Kösel S; Schnabel R; Mehraein P; Graeber MB
    Acta Neuropathol; 1995; 90(3):257-65. PubMed ID: 8525799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and genetic testing.
    Karlinsky H; Lennox A; Rossor M
    Alzheimer Dis Assoc Disord; 1994; 8(2):63-5; discussion 66-7. PubMed ID: 8060607
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current genetic linkages of Alzheimer's disease].
    Haltia M
    Duodecim; 1995; 111(5):389-92. PubMed ID: 8674440
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of apolipoprotein E genotype on biochemical markers of Alzheimer's disease.
    Schenk D; Lieberburg I; Motter R; Seubert P
    Ann N Y Acad Sci; 1996 Dec; 802():92-100. PubMed ID: 8993488
    [No Abstract]   [Full Text] [Related]  

  • 13. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 14. Alzheimer's disease: genotypes, phenotypes, and treatments.
    Selkoe DJ
    Science; 1997 Jan; 275(5300):630-1. PubMed ID: 9019820
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein E genotype does not affect age at onset in patients with chromosome 14 encoded Alzheimer's disease.
    J Med Genet; 1996 Feb; 33(2):174-5. PubMed ID: 8929962
    [No Abstract]   [Full Text] [Related]  

  • 16. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
    Sudo S; Shiozawa M; Cairns NJ; Wada Y
    J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
    Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
    Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Apolipoprotein E4 and Alzheimer's disease].
    Mori S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():812-7. PubMed ID: 11347179
    [No Abstract]   [Full Text] [Related]  

  • 19. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
    Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
    Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
    Hyman BT; Gomez-Isla T; West H; Briggs M; Chung H; Growdon JH; Rebeck GW
    Ann N Y Acad Sci; 1996 Jan; 777():158-65. PubMed ID: 8624079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.